News brief­ing: PhI­II Alzheimer's play draws an­oth­er $33M+; Ar­ran­ta un­veils $100M+ mi­cro­bio­me man­u­fac­tur­ing site

More mon­ey is flow­ing to­wards the dis­as­ter-prone yet high­ly sought af­ter quest for an Alzheimer’s dis­ease treat­ment. To­day, it is AZTher­a­pies’s turn to rake it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER